Soligenix Inc. Stock
Soligenix Inc. Stock
The community is currently still undecided about Soligenix Inc. with 1 Buy predictions and 0 Sell predictions.
On the other hand, the target price of 5 € is below the current price of 5.85 € for Soligenix Inc., so the potential is actually -14.53%.
So far the community has only identified positive things for Soligenix Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Soligenix Inc. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Soligenix Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Soligenix Inc. | - | - | - | - | - | - | - |
| Protara Therapeutics Inc. | -4.800% | 6.383% | 7.296% | -6.542% | -2.913% | 79.856% | -70.588% |
| India Globalization Capital | 2.190% | 14.167% | -5.517% | -22.599% | -18.452% | -16.844% | -79.233% |
| BioInvent International AB | 1.200% | -1.961% | -5.123% | -27.536% | -24.699% | -22.840% | -35.317% |
Comments
Soligenix Inc. (NASDAQ: SNGX) had its price target lowered by analysts at Alliance Global Partners from $10.00 to $6.00. They now have a "buy" rating on the stock.
Show more
Ratings data for SNGX provided by MarketBeat